Apteegikaubanduse Hulgimüük OÜ
Activity
Apteegikaubanduse Hulgimüük OÜ is a medium enterprise in trade, with declared activity “Ravimite ja muude apteegikaupade hulgimüük” (EMTAK 46461). Annual revenue stands at 12.25 M € with 10 employees, ranks #437 of 27,718 in trade.
Public procurement
Contract value
36.07 M €
Contracts
247
Buyers
16
Most recent
2026-03-23
| Buyer | Value | Year | |
|---|---|---|---|
| Infektsioonivastased ravimid | Aktsiaselts Lääne-Tallinna Keskhaigla | 3.03 M € | 2023 |
| Süstitavate antibiootikumide ostmine | Tervisekassa | 2.98 M € | 2024 |
| Süstitavate antibiootikumide ostmine 2025 | Tervisekassa | 2.55 M € | 2025 |
| Antiretroviirusravimite ostmine | Tervisekassa | 1.91 M € | 2025 |
| Kasvajavastased ravimid, endokrinoloogilised ravimid, immuunostimulaatorid, kasvajavastase ravi toksilise toime vastased raviained, diagnostilised ained, teised süsteemsed hemostaatilised ained | sihtasutus Põhja-Eesti Regionaalhaigla | 1.00 M € | 2023 |
| Antineoplastilised ravimid | sihtasutus Tartu Ülikooli Kliinikum | 882.0 k € | 2026 |
| Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained | sihtasutus Põhja-Eesti Regionaalhaigla | 800.0 k € | 2025 |
| Varia grupi ravimid (V-grupp) | Aktsiaselts Ida-Tallinna Keskhaigla | 662.7 k € | 2024 |
| Antineoplastilised ravimid | sihtasutus Tartu Ülikooli Kliinikum | 614.6 k € | 2024 |
| Antineoplastilised ja immunosupresseerivad ravimid | sihtasutus Tartu Ülikooli Kliinikum | 608.8 k € | 2025 |
Court decisions
- 3-22-2313Administrative2022-11-18Read on Riigikohus →
Overview (2024)
Revenue
12.25 M €
▲ 20.0%YoY
▲ 505×above industry median
Profit
1.43 M €
▲ 102%YoY
Profit margin
11.7%
Employees
10
▲ 25.0%YoY
Revenue per employee
1.22 M €
Cost per employee
39.6 k €
Equity
3.38 M €
Growth
Revenue
12.25 M €
▲ 20.0%
1y
▲ 38.4%
3y CAGR
—
5y CAGR
Profit
1.43 M €
▲ 102%
1y
▲ 70.3%
3y CAGR
—
5y CAGR
Employees
10
▲ 25.0%
1y
▲ 18.6%
3y CAGR
—
5y CAGR
Trends
Revenue trend
12.25 M €
Profit trend
1.43 M €
Headcount trend
10
Revenue to profit
Capital structure
- Equity71%
- Liabilities29%
Financials
| Year | Revenue | Growth | Profit | Margin | Employees | Revenue per employee | Equity |
|---|---|---|---|---|---|---|---|
| 2024 ✓ | 12.25 M € | ▲ 20.0% | 1.43 M € | 12% | 10 | 1.22 M € | 3.38 M € |
| 2023 ✓ | 10.20 M € | ▲ 60.5% | 709.6 k € | 7% | 8 | 1.28 M € | 2.51 M € |
| 2022 ✓ | 6.36 M € | ▲ 37.8% | 472.9 k € | 7% | 7 | 908.5 k € | 1.94 M € |
| 2021 ✓ | 4.62 M € | ▲ 33.0% | 290.4 k € | 6% | 6 | 769.3 k € | 1.41 M € |
| 2020 ✓ | 3.47 M € | — | 697.2 k € | 20% | 6 | 578.5 k € | 1.12 M € |
| 2019 | — | — | — | — | — | — | — |
Similar companies
- Trade2023 OÜ
- Osaühing Arctica Ref
- Aktsiaselts FRELOK
- AS Oribalt Tallinn
- Aktsiaselts Saurix Petroleum
- AB Medical Group Eesti osaühing
- Osaühing Kliimaseade
- JBC Europe OÜ
Directors' other companies
- Connecta OÜ
- MHM Invest OÜ
- Auxilia Pharma OÜ
- Wismo OÜ
- Hemptec OÜ
- Farmatar OÜ
- Osaühing Pharmax Group
- Artherix OÜ
- Hemptec Health OÜ
Official announcements
View announcements on Ametlikud Teadaanded →
Court rulings
Search court rulings on Riigi Teataja →
General info
- Address: Harju maakond, Tallinn, Kesklinna linnaosa, Pärnu mnt 141
- Registered: 2013-12-30
- VAT no.: EE101770145
- View in Business Register
Shareholders
Ownership chain
- MHM Invest OÜ50.00%
- Martin Henning100.00%
- Wismo OÜ50.00%
- Maido Mölder100.00%
Beneficial owners
Board (2)
- Maido Mölder — Juhatuse liige (since 2020-03-30)
- Martin Henning — Juhatuse liige (since 2017-03-20)